Health and Quality of Life Outcomes is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
We are recruiting!
Health and Quality of Life Outcomes is recruiting Associate Editors. As the growth of the journal continues, we are looking to expand our editorial team. If you have experience in health-related quality of life research and analysis, we would like to hear from you. Please follow the link below to find out more about the role and apply.Apply Now
During 2020, Health and Quality of Life Outcomes underwent a change in leadership with Mark Oremus (School of Public Health and Health Systems, University of Waterloo) and Oliver Rivero-Arias (Nuffield Department of Population Health, University of Oxford) being named Editors-in-Chief.
Their first objective was to streamline the Aims and Scope of the journal to focus specifically on health-related quality of life. For a full insight into the renewed Health and Quality of Life Outcomes leadership, and their collective vision for the journal, read their recent Editorial.
Editorial excellence at HQLO
Springer Nature recently awarded Health and Quality of Life Outcomes editors with 14 commendations for their excellence in editorial leadership, service to authors and their contributions to the journal. Click below to find out more!
Sign up to receive article alerts
Artificial Intelligence (AI) use
AI is emerging as a great tool for researchers, but make sure you are compliant with our editorial policies before you submit:
Read BMC’s editorial policy and the STM white paper on AI ethics in scholarly literature for more guidance. Contact our Editorial Office if you have any other questions.
Aims and scope
Health and Quality of Life Outcomes is an open access, peer-reviewed journal offering rapid publication and wide diffusion in the public domain of high-quality articles in the field of Health-Related Quality of Life (HRQOL).
Health and Quality of Life Outcomes considers original research manuscripts using appropriate quantitative or qualitative methods, systematic reviews/meta-analyses, seminar papers, study protocols, commentaries on articles, and letters to the editor where the main focus is HRQOL. We welcome contributions in the following areas:
- Hypothesis-based or theory-driven primary or secondary analyses using observational or experimental data using HRQOL information as an independent or dependent variable;
- Systematic reviews and/or meta-analyses of HRQOL studies following appropriate reporting guidelines (e.g., PRISMA);
- Articles describing novel theoretical frameworks created to underpin the development or use of HRQOL instruments;
- Submissions describing the psychometric properties of instruments measuring HRQOL or similar patient reported outcomes, including the validation of existing instruments in new populations, settings, or contexts;
- Methodological and applied research using preference elicitation exercises to report the estimation of value sets to inform health valuation; and
- Study protocols of planned or ongoing research studies, provided data collection is not complete and analyses have not yet begun.
To encourage the submission of high-quality work, all manuscripts submitted to the journal should conform to the relevant reporting guidelines (e.g., PRISMA, PRISMA-P, MOOSE, STROBE, CONSORT). Systematic reviews/meta-analyses and randomized controlled trials will only be considered for publication if they are preceded by a registry listing (e.g., PROSPERO, clinicaltrials.gov) or a published study protocol.
Mark Oremus, co-Editor-in-Chief
Dr Mark Oremus is an Associate Professor in the School of Public Health and Health Systems at the University of Waterloo, Canada. He holds a PhD in Epidemiology and Biostatistics from McGill University.
Dr Oremus' primary research interests include aging and chronic disease, cognition, dementia, and Alzheimer’s disease. He has conducted studies on willingness-to-pay for Alzheimer’s disease medications, measuring quality-of-life in Alzheimer’s disease, and the use of outcome measurement instruments in Alzheimer’s disease drug trials. His other research interests include systematic reviews, population and public health from a life-course perspective, health policy and economics, and knowledge transfer.
Oliver Rivero-Arias, co-Editor-in-Chief
Dr Oliver Rivero-Arias is an Associate Professor at the Nuffield Department of Population Health (NDPH) at the University of Oxford. He is the Senior Health Economist at the National Perinatal Epidemiology Unit based in the NDPH and holds a DPhil in Public Health from the University of Oxford. His main research interests concern the use of robust and appropriate methods to measure and value costs and benefits for the conduct of economic evaluations of interventions during pregnancy, childbirth, the newborn period and early childhood. His research agenda focuses on developing best practices to measure and value health-related quality of life (HRQoL) in cost-effectiveness analysis and he currently leads a programme of work around valuing health to inform healthcare decision-making in child and adolescent populations.
Annual Journal Metrics
2022 Citation Impact
3.6 - 2-year Impact Factor
4.1 - 5-year Impact Factor
1.550 - SNIP (Source Normalized Impact per Paper)
0.993 - SJR (SCImago Journal Rank)
7 days submission to first editorial decision for all manuscripts (Median)
158 days submission to accept (Median)
2,308 Altmetric mentions